Données sur la mortalité en France : principales causes de décès en 2008 et évolutions depuis 2000 Bulletin épidémioloque hebdomadaireInduction of anchorage-independent growth by amphiregulin, Growth Factors, vol.22, issue.13, pp.249-2553, 1996. ,
The mitochondrial apoptosome: a killer unleashed by the cytochrome seas, Trends in Biochemical Sciences, vol.26, issue.6, pp.390-397, 2001. ,
DOI : 10.1016/S0968-0004(01)01844-8
The Role of HDAC6 in Cancer, Journal of Biomedicine and Biotechnology, vol.421, issue.6920, p.875824, 2011. ,
DOI : 10.1091/mbc.E06-01-0008
Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer, Cancer Res, vol.65, issue.1, pp.226-235, 2005. ,
Modulating molecular chaperone Hsp90 functions through reversible acetylation, Trends in Cell Biology, vol.15, issue.11, pp.565-567, 2005. ,
DOI : 10.1016/j.tcb.2005.09.003
Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?, The Oncologist, vol.7, issue.90004, pp.31-39, 2002. ,
DOI : 10.1634/theoncologist.7-suppl_4-31
A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations, British Journal of Cancer, vol.311, issue.8, pp.998-1004, 2006. ,
DOI : 10.1093/annonc/mdi340
Death Receptors: Signaling and Modulation, Science, vol.281, issue.5381, pp.1305-1308, 1998. ,
DOI : 10.1126/science.281.5381.1305
Mechanism of Sirtuin Inhibition by Nicotinamide: Altering the NAD+ Cosubstrate Specificity of a Sir2 Enzyme, Molecular Cell, vol.17, issue.6, pp.855-868, 2005. ,
DOI : 10.1016/j.molcel.2005.02.022
Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors, Clinical Cancer Research, vol.12, issue.21, pp.6494-6501, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-1570
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90: A NOVEL BASIS FOR ANTILEUKEMIA ACTIVITY OF HISTONE DEACETYLASE INHIBITORS, Journal of Biological Chemistry, vol.280, issue.29, pp.26729-26734, 2005. ,
DOI : 10.1074/jbc.C500186200
ras Genes, Annual Review of Biochemistry, vol.56, issue.1, pp.779-827, 1987. ,
DOI : 10.1146/annurev.bi.56.070187.004023
Cytotoxic T lymphocytes: all roads lead to death, Nat Rev Immunol, vol.2, issue.6, pp.401-409, 2002. ,
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib, Proceedings of the National Academy of Sciences, vol.104, issue.52, pp.20932-20937, 2007. ,
DOI : 10.1073/pnas.0710370104
The 2004 World Health Organization classification of lung tumors, Seminars in Roentgenology, vol.40, issue.2, pp.90-97, 2005. ,
DOI : 10.1053/j.ro.2005.01.001
Estimation nationale de l'incidence et de la mortalité par cancer en France entre Institut de veille sanitaire 132pEpidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities, J Biol Chem, vol.271, issue.11, pp.6071-6076, 1980. ,
Molecular biology. The histone modification circus, Science, vol.292, issue.5514, pp.64-65, 2001. ,
Role of the Tetradecapeptide Repeat Domain of Human Histone Deacetylase 6 in Cytoplasmic Retention, Journal of Biological Chemistry, vol.279, issue.46, pp.48246-48254, 2004. ,
DOI : 10.1074/jbc.M408583200
Met, metastasis, motility and more, Nature Reviews Molecular Cell Biology, vol.4, issue.12, pp.915-925, 2003. ,
DOI : 10.1038/nrm1261
TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINS, Annual Review of Cell and Developmental Biology, vol.14, issue.1, pp.167-196, 1998. ,
DOI : 10.1146/annurev.cellbio.14.1.167
Opinion: Telomerase beyond telomeres, Nature Reviews Cancer, vol.2, issue.8, pp.627-633, 2002. ,
DOI : 10.1038/nrc862
TRAIL receptor-2 signals apoptosis through FADD and caspase- 8, Nat Cell Biol, vol.2, issue.4, pp.241-243, 2000. ,
Pathogenesis of lung cancer signalling pathways: roadmap for therapies, European Respiratory Journal, vol.33, issue.6, pp.1485-1497, 2009. ,
DOI : 10.1183/09031936.00014009
Cloning and characterization of a novel human histone deacetylase, HDAC8, Biochem J 350 Pt, vol.1, pp.199-205, 2000. ,
HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma, Blood, vol.117, issue.10, pp.2910-2917, 2011. ,
DOI : 10.1182/blood-2010-08-303701
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors, Molecular Cell, vol.12, issue.3, pp.541-552, 2003. ,
DOI : 10.1016/S1097-2765(03)00350-2
The multiple roles of amphiregulin in human cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1816, issue.2, pp.119-131, 2011. ,
DOI : 10.1016/j.bbcan.2011.05.003
URL : https://hal.archives-ouvertes.fr/inserm-00602082
Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers, Molecular Therapy, vol.18, issue.3, pp.528-535, 2010. ,
DOI : 10.1038/mt.2009.226
URL : https://hal.archives-ouvertes.fr/inserm-00425468
Amphiregulin Promotes Resistance to Gefitinib in NonSmall Cell Lung Cancer Cells by Regulating Ku70 Acetylation, Molecular Therapy, vol.18, issue.3, pp.536-543, 2010. ,
DOI : 10.1038/mt.2009.227
URL : https://hal.archives-ouvertes.fr/inserm-00425467
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A, Journal of the American Chemical Society, vol.132, issue.31, pp.10842-10846, 2010. ,
DOI : 10.1021/ja102758v
Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non-Small-Cell Lung Cancer, JNCI Journal of the National Cancer Institute, vol.97, issue.9, pp.643-655, 2005. ,
DOI : 10.1093/jnci/dji112
Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor???Positive Non???Small-Cell Lung Cancer Patients, Journal of Clinical Oncology, vol.23, issue.22, pp.5007-5018, 2005. ,
DOI : 10.1200/JCO.2005.09.111
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study, The Lancet Oncology, vol.11, issue.6, pp.521-529, 2010. ,
DOI : 10.1016/S1470-2045(10)70112-1
Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity, Proceedings of the National Academy of Sciences, vol.96, issue.22, pp.96-12356, 1999. ,
DOI : 10.1073/pnas.96.22.12356
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro, Nature, vol.199, issue.5686, pp.409-410, 1978. ,
DOI : 10.1016/0014-5793(77)80489-4
Immunit?? anti-tumorale et th??rapies cellulaires du cancer, m??decine/sciences, vol.19, issue.1, pp.43-53, 2003. ,
DOI : 10.1051/medsci/200319143
Dissecting p53-dependent apoptosis, Cell Death and Differentiation, vol.285, issue.6, pp.994-1002, 2006. ,
DOI : 10.1038/sj.cdd.4401908
Amphiregulin Causes Functional Downregulation of Adherens Junctions in Psoriasis, Journal of Investigative Dermatology, vol.124, issue.6, pp.1134-1140, 2005. ,
DOI : 10.1111/j.0022-202X.2005.23762.x
The deaf and the dumb: the biology of ErbB-2 and ErbB-3, Experimental Cell Research, vol.284, issue.1, pp.54-65, 2003. ,
DOI : 10.1016/S0014-4827(02)00101-5
Neuronal death in the central nervous system during development, Biomedicine & Pharmacotherapy, vol.52, issue.9, pp.356-362, 1998. ,
DOI : 10.1016/S0753-3322(99)80002-X
Acetylation of the C Terminus of Ku70 by CBP and PCAF Controls Bax-Mediated Apoptosis, Molecular Cell, vol.13, issue.5, pp.627-638, 2004. ,
DOI : 10.1016/S1097-2765(04)00094-2
A General Theory of Carcinogenesis, Proceedings of the National Academy of Sciences, vol.70, issue.12, pp.3324-3328, 1973. ,
DOI : 10.1073/pnas.70.12.3324
Expression and function of ErbB receptors and ligands in the pituitary, Endocrine Related Cancer, vol.18, issue.6, pp.197-211, 2011. ,
DOI : 10.1530/ERC-11-0066
The bcl2 family: regulators of the cellular life-or-death switch, Nature Reviews Cancer, vol.2, issue.9, pp.647-656, 2002. ,
DOI : 10.1038/nrc883
Regulated nucleosome mobility and the histone code, Nature Structural & Molecular Biology, vol.21, issue.11, pp.1037-1043, 2004. ,
DOI : 10.1101/gad.872801
BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations, PLoS Medicine, vol.25, issue.10, pp.1669-1679, 2007. ,
DOI : 10.1371/journal.pmed.0040315.st001
Caspase-activation pathways in apoptosis and immunity, Immunological Reviews, vol.8, issue.1, pp.10-21, 2003. ,
DOI : 10.1074/jbc.M101415200
Histone deacetylases, transcriptional control, and cancer, Journal of Cellular Physiology, vol.271, issue.1, pp.1-16, 2000. ,
DOI : 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7
Gefitinib Versus Vinorelbine in Chemotherapy-Na??ve Elderly Patients With Advanced Non???Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study, Journal of Clinical Oncology, vol.26, issue.26, pp.4253-4260, 2008. ,
DOI : 10.1200/JCO.2007.15.0672
Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer, Anti-Cancer Drugs, vol.17, issue.4, pp.401-409, 2006. ,
DOI : 10.1097/01.cad.0000203381.99490.ab
Cancers bronchopulmonaires primitifs non à petites cellules et tumeurs à malignité réduite EMC-pneumologie (6-002-H-20): 16 p D'Incecco, A. and FGefitinib for non-small-cell lung cancer treatment, Cappuzzo Expert Opin Drug Saf, vol.10, issue.6, pp.987-96, 1998. ,
EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells, Int J Cancer, vol.80, issue.4, pp.589-594, 1999. ,
Death receptors in chemotherapy and cancer, Oncogene, vol.23, issue.16, pp.2950-2966, 2004. ,
DOI : 10.1038/sj.onc.1207558
Targeting RAS signalling pathways in cancer therapy, Nature Reviews Cancer, vol.3, issue.1, pp.11-22, 2003. ,
DOI : 10.1038/nrc969
Role of ADAMs in Cancer Formation and Progression, Clinical Cancer Research, vol.15, issue.4, pp.1140-1144, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1585
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis, Annual Review of Biochemistry, vol.68, issue.1, pp.383-424, 1999. ,
DOI : 10.1146/annurev.biochem.68.1.383
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non???Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib, Journal of Clinical Oncology, vol.23, issue.25, pp.5900-5909, 2005. ,
DOI : 10.1200/JCO.2005.02.857
Lung cancer mortality in France, Lung Cancer, vol.59, issue.3, pp.282-290, 2008. ,
DOI : 10.1016/j.lungcan.2007.10.012
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling, Science, vol.316, issue.5827, pp.1039-1043, 2007. ,
DOI : 10.1126/science.1141478
Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells, Clinical Cancer Research, vol.12, issue.13, pp.4103-4111, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-2404
Ligand-Dependent Nuclear Receptor Corepressor LCoR Functions by Histone Deacetylase-Dependent and -Independent Mechanisms, Molecular Cell, vol.11, issue.1, pp.139-150, 2003. ,
DOI : 10.1016/S1097-2765(03)00014-5
URL : http://doi.org/10.1016/s1097-2765(03)00014-5
Promoting apoptosis as a strategy for cancer drug discovery, Nature Reviews Cancer, vol.88, issue.11, pp.876-885, 2005. ,
DOI : 10.1038/nrc1361
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors, Nature, vol.401, issue.6749, pp.188-193, 1999. ,
Regulating the Regulators, Cell, vol.112, issue.1, pp.11-17, 2003. ,
DOI : 10.1016/S0092-8674(02)01278-3
Mechanism of action of erbB tyrosine kinase inhibitors, Experimental Cell Research, vol.284, issue.1, pp.131-139, 2003. ,
DOI : 10.1016/S0014-4827(02)00095-2
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.21, issue.12, pp.2237-2246, 2003. ,
DOI : 10.1200/JCO.2003.10.038
Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions, Journal of Biological Chemistry, vol.277, issue.22, pp.19618-19626, 2002. ,
DOI : 10.1074/jbc.M201174200
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non???Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial, Journal of Clinical Oncology, vol.25, issue.12, pp.1545-52, 2007. ,
DOI : 10.1200/JCO.2005.05.1474
Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family, Journal of Biological Chemistry, vol.277, issue.28, pp.25748-25755, 2002. ,
DOI : 10.1074/jbc.M111871200
The Microtubule-associated Histone Deacetylase 6 (HDAC6) Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation, Journal of Biological Chemistry, vol.285, issue.15, pp.11219-11226, 2010. ,
DOI : 10.1074/jbc.M109.042754
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas, Cancer Res, vol.53, issue.14, pp.3217-3220, 1993. ,
p300 Transcriptional Repression Is Mediated by SUMO Modification, Molecular Cell, vol.11, issue.4, pp.1043-1054, 2003. ,
DOI : 10.1016/S1097-2765(03)00141-2
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours, Journal of Thoracic Oncology, vol.2, issue.8, pp.706-714, 2007. ,
DOI : 10.1097/JTO.0b013e31812f3c1a
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants, PLoS Medicine, vol.57, issue.11, p.313, 2005. ,
DOI : 10.1371/journal.pmed.0020313.t002
URL : http://doi.org/10.1371/journal.pmed.0020313
Three proteins define a class of human histone deacetylases related to yeast Hda1p, Proceedings of the National Academy of Sciences, vol.96, issue.9, pp.4868-4873, 1999. ,
DOI : 10.1073/pnas.96.9.4868
Molecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10, Journal of Biological Chemistry, vol.277, issue.5, pp.3350-3356, 2002. ,
DOI : 10.1074/jbc.M109861200
Lung cancer screening: current situation and perspective, Swiss Med Wkly, vol.137, pp.21-22, 2007. ,
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation, Proceedings of the National Academy of Sciences, vol.100, issue.8, pp.4389-4394, 2003. ,
DOI : 10.1073/pnas.0430973100
The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000. ,
DOI : 10.1016/S0092-8674(00)81683-9
A complex containing N-CoR, mSln3 and histone
deacetylase mediates transcriptional repression, nature, vol.387, issue.6628, pp.43-48, 1997. ,
DOI : 10.1038/387043a0
Targeting the epidermal growth factor receptor in non-small cell lung cancer, Clin Cancer Res, vol.916, issue.1, pp.5813-5824, 2003. ,
Lung Cancer, New England Journal of Medicine, vol.359, issue.13, pp.1367-1380, 2008. ,
DOI : 10.1056/NEJMra0802714
Cellular stress response and apoptosis in cancer therapy, Blood, vol.98, issue.9, pp.2603-2614, 2001. ,
DOI : 10.1182/blood.V98.9.2603
Évolution de la mortalité par cancer en France de Saint- Maurice (Fra) : Institut de veille sanitaire. 272p. Disponible sur: www.invs.santéEpidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis, J Clin Oncol, vol.21, issue.20, pp.3798-3807, 1950. ,
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib, Annals of Oncology, vol.18, issue.4, pp.752-760, 2007. ,
DOI : 10.1093/annonc/mdm003
Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study, Journal of Clinical Oncology, vol.23, issue.28, pp.6838-6845, 2005. ,
DOI : 10.1200/JCO.2005.01.2823
The ErbB receptors and their role in cancer progression, Experimental Cell Research, vol.284, issue.1, pp.99-110, 2003. ,
DOI : 10.1016/S0014-4827(02)00099-X
: Directing Key Signaling Networks Throughout Life, Annual Review of Pharmacology and Toxicology, vol.44, issue.1, pp.195-217, 2004. ,
DOI : 10.1146/annurev.pharmtox.44.101802.121440
Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes, Proceedings of the National Academy of Sciences, vol.99, issue.21, pp.99-13425, 2002. ,
DOI : 10.1073/pnas.172511699
Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor, Journal of Biological Chemistry, vol.275, issue.20, pp.15254-15264, 2000. ,
DOI : 10.1074/jbc.M908988199
HDAC6 is a microtubule-associated deacetylase, Nature, vol.417, issue.6887, pp.455-458, 2002. ,
DOI : 10.1038/417455a
Cooperation of Amphiregulin and Insulin-like Growth Factor-1 Inhibits Bax- and Bad-mediated Apoptosis via a Protein Kinase C-dependent Pathway in Non-small Cell Lung Cancer Cells, Journal of Biological Chemistry, vol.280, issue.20, pp.19757-19767, 2005. ,
DOI : 10.1074/jbc.M413516200
URL : https://hal.archives-ouvertes.fr/inserm-00340599
Inhibition of Apoptosis by Amphiregulin via an Insulin-like Growth Factor-1 Receptor-dependent Pathway in Non-small Cell Lung Cancer Cell Lines, Journal of Biological Chemistry, vol.277, issue.51, pp.49127-49133, 2002. ,
DOI : 10.1074/jbc.M207584200
Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma, The Journal of Pathology, vol.3, issue.1, pp.83-95, 2011. ,
DOI : 10.1002/path.2897
URL : https://hal.archives-ouvertes.fr/inserm-00598462
ERBB receptors and cancer: the complexity of targeted inhibitors, Nature Reviews Cancer, vol.7, issue.5, pp.341-354, 2005. ,
DOI : 10.1021/jm00130a020
Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases, Trends in Pharmacological Sciences, vol.31, issue.5, pp.212-220, 2010. ,
DOI : 10.1016/j.tips.2010.02.003
Cancer du poumon Prise en charge thérapeutique du cancer du poumon non à petites cellules. Institut Nationale du Cancer 30p, 2010. ,
Prospective Phase II Study of Gefitinib for Chemotherapy-Na??ve Patients With Advanced Non???Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations, Journal of Clinical Oncology, vol.24, issue.21, pp.3340-3346, 2006. ,
DOI : 10.1200/JCO.2005.05.4692
Projection de l'incidence et de la mortalité par cancer en France en 2011 Rapport technique Saint-Maurice: Institut de veille sanitaire 78 p. Disponible sur: www.invs.santé.fr IshikawaIncreases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers, InVS Cancer Res, vol.65, issue.20, pp.9176-9184, 2005. ,
Activating mutations for the Met tyrosine kinase receptor in human cancer, Proceedings of the National Academy of Sciences, vol.94, issue.21, pp.11445-11450, 1997. ,
DOI : 10.1073/pnas.94.21.11445
Apoptosis, Cell, vol.108, issue.2, pp.153-164, 2002. ,
DOI : 10.1016/S0092-8674(02)00625-6
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839), Human Molecular Genetics, vol.13, issue.24, pp.3029-3043, 2004. ,
DOI : 10.1093/hmg/ddh331
Effects of downregulated HDAC6 expression on the proliferation of lung cancer cells, Biochemical and Biophysical Research Communications, vol.374, issue.1, pp.84-89, 2008. ,
DOI : 10.1016/j.bbrc.2008.06.092
Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression, Genes Dev, vol.14, issue.1, pp.55-66, 2000. ,
HDAC3: taking the SMRT-N-CoRrect road to repression, Oncogene, vol.158, issue.37, pp.5439-5449, 2007. ,
DOI : 10.1128/MCB.24.12.5106-5118.2004
Amphiregulin Mediates Estrogen, Progesterone, and EGFR Signaling in the Normal Rat Mammary Gland and in Hormone-Dependent Rat Mammary Cancers, Hormones and Cancer, vol.150, issue.Suppl 1, pp.229-244, 2010. ,
DOI : 10.1007/s12672-010-0048-0
Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5, Biochemical and Biophysical Research Communications, vol.301, issue.4, pp.1109-1115, 2003. ,
DOI : 10.1016/S0006-291X(03)00093-7
Induction of Apoptosis by Cancer Chemotherapy, Experimental Cell Research, vol.256, issue.1, pp.42-49, 2000. ,
DOI : 10.1006/excr.2000.4838
Detection of K-ras mutations in lung carcinomas: relationship to prognosis, Clin Cancer Res, vol.2, issue.2, pp.411-418, 1996. ,
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial, The Lancet, vol.372, issue.9652, pp.1809-1818, 2008. ,
DOI : 10.1016/S0140-6736(08)61758-4
Effects of reclassification from the TNM-6 into the TNM-7 staging system in bronchoplastic resection for non-small cell lung cancer, Interactive CardioVascular and Thoracic Surgery, vol.13, issue.1, pp.29-34, 2011. ,
DOI : 10.1510/icvts.2011.267021
Mutation and Resistance of Non???Small-Cell Lung Cancer to Gefitinib, New England Journal of Medicine, vol.352, issue.8, pp.786-792, 2005. ,
DOI : 10.1056/NEJMoa044238
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non???Small Cell Lung Cancer, JAMA, vol.290, issue.16, pp.2149-2158, 2003. ,
DOI : 10.1001/jama.290.16.2149
Histone Deacetylase 10 Relieves Repression on the Melanogenic Program by Maintaining the Deacetylation Status of Repressors, Journal of Biological Chemistry, vol.285, issue.10, pp.7187-7196, 2010. ,
DOI : 10.1074/jbc.M109.061861
Consommation de tabac par catégorie socioprofessionnelle et secteur d'activité, 2010. ,
Protein Kinase InhibitorsThe Tyrosine-Specific Protein Kinases, Pharmacology & Therapeutics, vol.77, issue.2, pp.81-114, 1998. ,
DOI : 10.1016/S0163-7258(97)00052-1
Histone deacetylase activity is required for embryonic stem cell differentiation, genesis, vol.29, issue.1, pp.32-38, 2004. ,
DOI : 10.1002/gene.10250
Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells, Molecules and Cells, vol.98, issue.2, pp.107-112, 2010. ,
DOI : 10.1007/s10059-010-0094-z
A randomized phase III study of gefitinib versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never-smokers with advanced or metastatic adenocarcinoma of the lung, J Thorac Oncol, vol.4, issue.1, p.283, 2009. ,
The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis, Cancer Research, vol.68, issue.18, pp.7561-7569, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0188
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis, Cell, vol.94, issue.4, pp.491-501, 1998. ,
DOI : 10.1016/S0092-8674(00)81590-1
Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression, Genes & Development, vol.16, issue.6, pp.687-692, 2002. ,
DOI : 10.1101/gad.962502
Endonuclease G is an apoptotic DNase when released from mitochondria, Nature, vol.412, issue.6842, pp.95-99, 2001. ,
DOI : 10.1038/35083620
Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells, Glia, vol.77, issue.1, pp.1-12, 2009. ,
DOI : 10.1002/glia.20729
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases, Proceedings of the National Academy of Sciences, vol.97, issue.8, pp.4070-4075, 2000. ,
DOI : 10.1073/pnas.080064097
Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006???2009, British Journal of Cancer, vol.7, issue.6, pp.1068-1075, 2006. ,
DOI : 10.1038/sj.bjc.6602506
European cancer mortality predictions for the year 2012, Annals of Oncology, vol.23, issue.4, pp.1044-1052, 2012. ,
DOI : 10.1093/annonc/mds024
Comparative study of the main characteristics and composition of the mainstream smoke of ten cigarette brands sold in Spain, Food and Chemical Toxicology, vol.50, issue.5, pp.1317-1333, 2012. ,
DOI : 10.1016/j.fct.2012.01.046
Class IIa histone deacetylases: regulating the regulators, Oncogene, vol.15, issue.37, pp.5450-5467, 2007. ,
DOI : 10.1073/pnas.250494697
Surgical treatment of non-small cell lung cancer by stage, Seminars in Surgical Oncology, vol.36, issue.5, pp.248-254, 1990. ,
DOI : 10.1002/ssu.2980060505
Gefitinib or Chemotherapy for Non???Small-Cell Lung Cancer with Mutated EGFR, New England Journal of Medicine, vol.362, issue.25, pp.2380-2388, 2010. ,
DOI : 10.1056/NEJMoa0909530
Membrane-Anchored Growth Factors, Annual Review of Biochemistry, vol.62, issue.1, pp.515-541, 1993. ,
DOI : 10.1146/annurev.bi.62.070193.002503
KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer, Clinical Cancer Research, vol.13, issue.10, pp.2890-2896, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-3043
In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation, The EMBO Journal, vol.21, issue.24, pp.6820-6831, 2002. ,
DOI : 10.1093/emboj/cdf682
Pathways towards and away from Alzheimer's disease, Nature, vol.22, issue.7000, pp.631-639, 2004. ,
DOI : 10.1016/j.molcel.2003.08.005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091392
MEF2: a calcium-dependent regulator of cell division, differentiation and death, Trends in Biochemical Sciences, vol.27, issue.1, pp.40-47, 2002. ,
DOI : 10.1016/S0968-0004(01)02031-X
Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs, Journal of Biological Chemistry, vol.274, issue.12, pp.7987-7992, 1999. ,
DOI : 10.1074/jbc.274.12.7987
Epithelial immaturity and multiorgan failure in mice lacking epidermal
growth factor receptor, Nature, vol.376, issue.6538, pp.337-341, 1995. ,
DOI : 10.1038/376337a0
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma, Oncogene, vol.88, issue.3, pp.409-418, 2006. ,
DOI : 10.1038/sj.onc.1209057
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, vol.9, issue.6, pp.1799-1805, 1994. ,
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, issue.2, pp.293-299, 1995. ,
Gefitinib or Carboplatin???Paclitaxel in Pulmonary Adenocarcinoma, New England Journal of Medicine, vol.361, issue.10, pp.947-957, 2009. ,
DOI : 10.1056/NEJMoa0810699
Implication of the Insulin-like Growth Factor-IR Pathway in the Resistance of Non small Cell Lung Cancer Cells to Treatment with Gefitinib, Clinical Cancer Research, vol.13, issue.9, pp.2795-2803, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2077
Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib, Cancer Research, vol.66, issue.20, pp.10100-10111, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-1684
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial, The Lancet Oncology, vol.11, issue.2, pp.121-128, 2010. ,
DOI : 10.1016/S1470-2045(09)70364-X
Transitions in Distinct Histone H3 Methylation Patterns at the Heterochromatin Domain Boundaries, Science, vol.293, issue.5532, pp.1150-1155, 2001. ,
DOI : 10.1126/science.1064150
Epidermal growth factor receptor (EGFR) signaling in cancer, Gene, vol.366, issue.1, pp.2-16, 2006. ,
DOI : 10.1016/j.gene.2005.10.018
Targeting of HDAC8 and investigational inhibitors in neuroblastoma, Expert Opinion on Investigational Drugs, vol.8, issue.3, pp.1605-1617, 2009. ,
DOI : 10.1073/pnas.0803749105
Differential Constitutive Activation of the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cells Bearing EGFR Gene Mutation and Amplification, Cancer Research, vol.67, issue.5, pp.2046-2053, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-3339
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer, The EMBO Journal, vol.19, issue.13, pp.3159-3167, 2000. ,
DOI : 10.1093/emboj/19.13.3159
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients, International Journal of Cancer, vol.112, issue.1, pp.26-32, 2004. ,
DOI : 10.1002/ijc.20395
Blockade of the ERK or PI3K???Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib, Biochemical and Biophysical Research Communications, vol.391, issue.4, pp.1610-1615, 2010. ,
DOI : 10.1016/j.bbrc.2009.12.086
Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non???Small-Cell Lung Cancer: Current Knowledge and Future Directions, Journal of Clinical Oncology, vol.23, issue.11, pp.2556-2568, 2005. ,
DOI : 10.1200/JCO.2005.07.799
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain, PLoS Medicine, vol.9, issue.3, p.73, 2005. ,
DOI : 10.1371/journal.pmed.0020073.sd001
Directed Therapies in Lung Cancer: New Hope?, Arch Bronconeumol, 2012. ,
A prospective phase II trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients (p) with mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR), ASCO annual Meeting, 2006. ,
The CD95(APO-1/Fas) DISC and beyond, Cell Death and Differentiation, vol.10, issue.1, pp.26-35, 2003. ,
DOI : 10.1038/sj.cdd.4401186
HER1/EGFR Targeting: Refining the Strategy, The Oncologist, vol.9, issue.1, pp.58-67, 2004. ,
DOI : 10.1634/theoncologist.9-1-58
Lymphocyte apoptosis: refining the paths to perdition, Current Opinion in Hematology, vol.9, issue.1, pp.43-49, 2002. ,
DOI : 10.1097/00062752-200201000-00008
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification, Endocrine Related Cancer, vol.8, issue.1, pp.11-31, 2001. ,
DOI : 10.1677/erc.0.0080011
Stimulation of amphiregulin expression in osteoblastic cells by parathyroid hormone requires the protein kinase A and cAMP response element-binding protein signaling pathway, Journal of Cellular Biochemistry, vol.138, issue.3, pp.632-640, 2005. ,
DOI : 10.1002/jcb.20550
Amphiregulin Is a Novel Growth Factor Involved in Normal Bone Development and in the Cellular Response to Parathyroid Hormone Stimulation, Journal of Biological Chemistry, vol.280, issue.5, pp.3974-3981, 2005. ,
DOI : 10.1074/jbc.M409807200
Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer, Lung Cancer, vol.63, issue.1, pp.1-9, 2009. ,
DOI : 10.1016/j.lungcan.2008.05.015
Dysregulation of Apoptosis in Cancer, Journal of Clinical Oncology, vol.17, issue.9, pp.2941-2953, 1999. ,
DOI : 10.1200/JCO.1999.17.9.2941
Molecular mechanisms of caspase regulation during apoptosis, Nature Reviews Molecular Cell Biology, vol.11, issue.11, pp.897-907, 2004. ,
DOI : 10.1107/S0021889891004399
Resumé des caracteistiques du produit Roche 21p Disponible sur www.roche.fr RodenhuisMutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung, N Engl J Med, issue.15, pp.317-929, 1987. ,
Histone Acetyltransferases, Annual Review of Biochemistry, vol.70, issue.1, pp.81-120, 2001. ,
DOI : 10.1146/annurev.biochem.70.1.81
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung, Cancer Res, vol.53, pp.2379-2385, 1993. ,
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands, The Journal of Cell Biology, vol.347, issue.5, pp.769-779, 2004. ,
DOI : 10.1128/MCB.24.1.96-104.2004
EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney, Am J Physiol, vol.2733, issue.2, pp.463-472, 1997. ,
Epidermal growth factor-related peptides and their receptors in human malignancies, Critical Reviews in Oncology/Hematology, vol.19, issue.3, pp.183-232, 1995. ,
DOI : 10.1016/1040-8428(94)00144-I
Dissecting the genetic alterations involved in lung carcinogenesis, Lung Cancer, vol.40, issue.2, pp.111-121, 2003. ,
DOI : 10.1016/S0169-5002(03)00033-3
Lung injury after cigarette smoking is particle related, Int J Chron Obstruct Pulmon Dis, vol.6, pp.191-198, 2011. ,
EGFR exon 20 insertion mutation in Japanese lung cancer, Lung Cancer, vol.58, issue.3, pp.324-328, 2007. ,
DOI : 10.1016/j.lungcan.2007.06.024
Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.25, issue.5, pp.587-595, 2007. ,
DOI : 10.1200/JCO.2006.07.3585
Mutations, Journal of Clinical Oncology, vol.26, issue.15, pp.2442-2449, 2008. ,
DOI : 10.1200/JCO.2007.14.8494
Comparison of Four Chemotherapy Regimens for Advanced Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.346, issue.2, pp.92-98, 2002. ,
DOI : 10.1056/NEJMoa011954
Amphiregulin in lung branching morphogenesis: interaction with heparan sulfate proteoglycan modulates cell proliferation, Development, vol.122, issue.6, pp.1759-1767, 1996. ,
Identification of Components of the Murine Histone Deacetylase 6 Complex: Link between Acetylation and Ubiquitination Signaling Pathways, Molecular and Cellular Biology, vol.21, issue.23, pp.8035-8044, 2001. ,
DOI : 10.1128/MCB.21.23.8035-8044.2001
URL : https://hal.archives-ouvertes.fr/hal-00380090
Epidermal growth factor receptor mutations in lung cancer, Nature Reviews Cancer, vol.64, issue.3, pp.169-181, 2007. ,
DOI : 10.1038/nrc2088
Erlotinib in Previously Treated Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.353, issue.2, pp.123-132, 2005. ,
DOI : 10.1056/NEJMoa050753
Surgical therapy for carcinoma of the lung, Clin Chest Med, vol.14, issue.1, pp.121-147, 1993. ,
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers, JNCI Journal of the National Cancer Institute, vol.97, issue.5, pp.339-346, 2005. ,
DOI : 10.1093/jnci/dji055
Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas, Cancer Research, vol.65, issue.5, pp.1642-1646, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-4235
Apoptosis and lung cancer: A review, Journal of Cellular Biochemistry, vol.64, issue.5, pp.885-898, 2003. ,
DOI : 10.1002/jcb.10440
Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7., Proceedings of the National Academy of Sciences, vol.85, issue.17, pp.85-6528, 1988. ,
DOI : 10.1073/pnas.85.17.6528
Strain-dependent epithelial defects in mice lacking the EGF receptor, Science, vol.269, issue.5221, pp.234-238, 1995. ,
DOI : 10.1126/science.7618085
ONCOGENIC TYROSINE KINASES AND THE DNA-DAMAGE RESPONSE, Nature Reviews Cancer, vol.2, issue.5, pp.351-360, 2002. ,
DOI : 10.1038/nrc799
Genetic Mechanisms of Chronic Myeloid Leukemia Blastic Transformation, Current Hematologic Malignancy Reports, vol.105, issue.2, pp.87-93, 2012. ,
DOI : 10.1007/s11899-012-0114-5
The ras gene family in human non-small-cell lung cancer, J Natl Cancer Inst Monogr, issue.13, pp.23-29, 1992. ,
Chemical mechanisms of histone lysine and arginine modifications, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1789, issue.1, pp.45-57, 2009. ,
DOI : 10.1016/j.bbagrm.2008.06.005
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752, Proceedings of the National Academy of Sciences, vol.103, issue.7, pp.2316-2321, 2006. ,
DOI : 10.1073/pnas.0508776103
Identification of the transforming EML4???ALK fusion gene in non-small-cell lung cancer, Nature, vol.276, issue.7153, pp.561-566, 2007. ,
DOI : 10.1038/nature05945
MEF-2 function is modified by a novel co-repressor, MITR, The EMBO Journal, vol.18, issue.18, pp.5085-5098, 1999. ,
DOI : 10.1093/emboj/18.18.5085
Caspases ??? controlling intracellular signals by protease zymogen activation, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol.1477, issue.1-2, pp.299-306, 2000. ,
DOI : 10.1016/S0167-4838(99)00281-2
Acetylation of Histones and Transcription-Related Factors, Microbiology and Molecular Biology Reviews, vol.64, issue.2, pp.435-459, 2000. ,
DOI : 10.1128/MMBR.64.2.435-459.2000
Current Treatments for Advanced Stage Non-Small Cell Lung Cancer, Proceedings of the American Thoracic Society, vol.6, issue.2, pp.233-241, 2009. ,
DOI : 10.1513/pats.200809-110LC
Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials, Expert Opinion on Investigational Drugs, vol.38, issue.4, pp.553-573, 1998. ,
DOI : 10.1126/science.276.5314.955
HDAC6 Deacetylates Ku70 and Regulates Ku70-Bax Binding in Neuroblastoma, Neoplasia, vol.13, issue.8, pp.726-734, 2011. ,
DOI : 10.1593/neo.11558
URL : http://doi.org/10.1593/neo.11558
HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors, Clinical Cancer Research, vol.15, issue.15, pp.4829-4837, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2921
Tumor Necrosis Factor-?? Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand Availability, Journal of Biological Chemistry, vol.277, issue.15, pp.12838-12845, 2002. ,
DOI : 10.1074/jbc.M112050200
Molecular characterization of mitochondrial apoptosisinducing factor, Nature, vol.397, issue.6718, pp.441-446, 1999. ,
Pharmacokinetics and Tolerability of the Orally Active Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Healthy Volunteers, Clinical Pharmacokinetics, vol.19, issue.4, pp.297-306, 2001. ,
DOI : 10.2165/00003088-200140040-00005
Exploring the Relationship Between Expression of Cytochrome P450??Enzymes and Gefitinib Pharmacokinetics, Clinical Pharmacokinetics, vol.27, issue.10, pp.633-644, 2006. ,
DOI : 10.2165/00003088-200645060-00006
Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol, Clinical Pharmacokinetics, vol.54, issue.10, pp.1067-1081, 2005. ,
DOI : 10.2165/00003088-200544100-00005
Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.23, issue.28, pp.6829-6837, 2005. ,
DOI : 10.1200/JCO.2005.01.0793
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403), British Journal of Cancer, vol.2, issue.5, pp.907-914, 2008. ,
DOI : 10.2353/jmoldx.2006.050104
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer), The Lancet, vol.366, issue.9496, pp.1527-1537, 2005. ,
DOI : 10.1016/S0140-6736(05)67625-8
Aspects épigénétiques des cancers broncho-pulmonaires et implication de l'histone acétyltransférase Tip60, 2009. ,
Apoptosis in Parkinson's disease: signals for neuronal degradation, Ann Neurol, vol.53, issue.3, pp.61-70, 2003. ,
Epidémiologie et facteurs de risque des cancers bronchiques primitifs, EMCpneumologie, vol.1, issue.1, pp.7-18, 2004. ,
DOI : 10.1016/s1155-195x(04)74551-x
Apoptosis in the pathogenesis and treatment of disease, Science, vol.267, issue.5203, pp.1456-1462, 1995. ,
DOI : 10.1126/science.7878464
Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype, Science, vol.269, issue.5221, pp.230-234, 1995. ,
DOI : 10.1126/science.7618084
Amphiregulin is expressed in primary cultures of prostate myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue, Prostate Cancer and Prostatic Diseases, vol.1, issue.5, pp.262-267, 1998. ,
DOI : 10.1038/sj.pcan.4500250
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma, Journal of Thoracic Oncology, vol.6, issue.2, pp.244-285, 2011. ,
DOI : 10.1097/JTO.0b013e318206a221
URL : https://hal.archives-ouvertes.fr/inserm-00561753
Co-expression of epidermal growth factor receptor and transforming growth factor-?? predicts worse prognosis in breast-cancer patients, International Journal of Cancer, vol.89, issue.6, pp.484-491, 2000. ,
DOI : 10.1002/1097-0215(20001120)89:6<484::AID-IJC3>3.0.CO;2-S
Morphological and Biochemical Aspects of Apoptosis, Oncosis and Necrosis, Anatomia, Histologia, Embryologia: Journal of Veterinary Medicine Series C, vol.68, issue.4, pp.214-223, 2002. ,
DOI : 10.1093/emboj/16.17.5386
Structure, function and transforming potential of the epidermal growth factor receptor, Molecular and Cellular Endocrinology, vol.70, issue.3, pp.205-216, 1990. ,
DOI : 10.1016/0303-7207(90)90211-P
Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm, Current Biology, vol.10, issue.12, pp.747-749, 2000. ,
DOI : 10.1016/S0960-9822(00)00542-X
Identification of a New Family of Higher Eukaryotic Histone Deacetylases: COORDINATE EXPRESSION OF DIFFERENTIATION-DEPENDENT CHROMATIN MODIFIERS, Journal of Biological Chemistry, vol.274, issue.4, pp.2440-2445, 1999. ,
DOI : 10.1074/jbc.274.4.2440
[Gemcitabine and non small-cell lung cancer], Cancer 94 Spec No Actualites, pp.95-103, 2007. ,
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance, Nature Immunology, vol.1, issue.1, pp.92-100, 2009. ,
DOI : 10.1038/ni.1673
Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas, Journal of Cancer Research and Clinical Oncology, vol.6, issue.9, pp.507-510, 1993. ,
DOI : 10.1007/BF01686458
Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin, Human Molecular Genetics, vol.10, issue.7, pp.693-698, 2001. ,
DOI : 10.1093/hmg/10.7.693
Epidermal growth factor receptor tyrosine kinase, Biochemical Pharmacology, vol.48, issue.4, pp.659-666, 1994. ,
DOI : 10.1016/0006-2952(94)90042-6
Signaling through ERBB receptors: Multiple layers of diversity and control, Cellular Signalling, vol.18, issue.7, pp.923-933, 2006. ,
DOI : 10.1016/j.cellsig.2005.12.007
Caspase activation in the terminal differentiation of human epidermal keratinocytes, Current Biology, vol.9, issue.7, pp.361-364, 1999. ,
DOI : 10.1016/S0960-9822(99)80162-6
EGF receptor, The International Journal of Biochemistry & Cell Biology, vol.31, issue.6, pp.637-643, 1999. ,
DOI : 10.1016/S1357-2725(99)00015-1
Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter, Molecular and Cellular Biology, vol.22, issue.22, pp.7982-7992, 2002. ,
DOI : 10.1128/MCB.22.22.7982-7992.2002
Global status report on noncommunicable diseases World Health Organization 176p WoodMesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos, WHO Development, vol.127, issue.24, pp.5245-5252, 2000. ,
Histone deacetylase inhibitors: molecular mechanisms of action, Oncogene, vol.3, issue.37, pp.5541-5552, 2007. ,
DOI : 10.1016/j.bbrc.2005.12.144
Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways, Cell Research, vol.21, issue.3, pp.161-167, 2000. ,
DOI : 10.1084/jem.182.5.1223
Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer, Journal of Thoracic Oncology, vol.2, issue.1, pp.22-30, 2007. ,
DOI : 10.1097/01243894-200701000-00006
CoREST is an integral component of the CoREST- human histone deacetylase complex, Proceedings of the National Academy of Sciences, vol.98, issue.4, pp.1454-1458, 2001. ,
DOI : 10.1073/pnas.98.4.1454
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP, Proceedings of the National Academy of Sciences, vol.105, issue.6, pp.2070-2075, 2008. ,
DOI : 10.1073/pnas.0709662105
Mechanisms for oncogenic activation of the epidermal growth factor receptor, Cellular Signalling, vol.19, issue.10, pp.2013-2023, 2007. ,
DOI : 10.1016/j.cellsig.2007.06.023
Two Catalytic Domains Are Required for Protein Deacetylation, Journal of Biological Chemistry, vol.281, issue.5, pp.2401-2404, 2006. ,
DOI : 10.1074/jbc.C500241200
URL : https://hal.archives-ouvertes.fr/inserm-00176759
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo, The EMBO Journal, vol.22, issue.5, pp.1168-1179, 2003. ,
DOI : 10.1093/emboj/cdg115
Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation, Genes & Development, vol.13, issue.15, pp.1924-1935, 1999. ,
DOI : 10.1101/gad.13.15.1924
Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis, Lung Cancer, vol.27, issue.1, pp.3-18, 2000. ,
DOI : 10.1016/S0169-5002(99)00093-8
Characterization of the two catalytic domains in histone deacetylase 6, Biochemical and Biophysical Research Communications, vol.341, issue.1, pp.45-50, 2006. ,
DOI : 10.1016/j.bbrc.2005.12.144